ertugliflozin/sitagliptin (Steglujan)

From Aaushi

Jump to navigation Jump to search

^[1]

Indications

treatment of diabetes mellitus type 2

Dosage

Tabs: ertugliflozin/sitagliptin 5 mg/100 mg, 15 mg/100 mg

More general terms

hypoglycemic combination

References

↑ Busko M FDA Approves SGLT2 Inhibitor Ertugliflozin for Type 2 Diabetes Medscape - Dec 21, 2017. https://www.medscape.com/viewarticle/890446

Retrieved from "https://aaushi.info/w/index.php?title=A54854&oldid=952267"

↑ Back to top